Cystic Fibrosis Clinical Trial
— PIN-CFOfficial title:
Pilot Study of Behavioural Intervention for Nutrition in Cystic Fibrosis
Cystic Fibrosis (CF) is a lifelong condition which causes the lungs and digestive system to
become clogged with thick, sticky mucus. This leads to recurrent lung infections and reduced
nutrients absorption from food. The average age at death is 26 years, usually from
respiratory failure. Nonetheless, the nutritional status of people with CF (PWCF) is
important help them live healthier and longer.
It is recommended that adult with CF achieve a BMI of 23 for males and 22 for females.
However, fewer than 50% adult with CF achieved that target BMI despite effective nutritional
support to help support weight gain. There is a clear need for a behavioural intervention
that can help PWCF use the available nutritional support.
This is a feasibility study to try out a multi-component behavioural intervention. The
intervention is designed to help PWCF use their nutritional support to gain weight. It will
focus on testing the methods and procedures to be used on a larger scale, improving the
behavioural intervention and estimating the how many people are needed for the larger trial.
All eligible 75 PWCF in Sheffield will be invited to participate. The investigators
anticipate recruiting 30 participants. Participants will be divided into two groups. The
first group receive the behavioural intervention immediately. The second group receive the
intervention after 3 months. All participants will be followed up for 6 months. Data will be
collected every 6 weeks during clinic reviews.
These two groups will be compared against each other to estimate the potential impact of the
behavioural intervention. The investigators will also interview some of the participants at
the end of the study period to improve the intervention and the study processes based on
participant feedback.
The investigators hypothesised that this study will recruit around 30 participants, around
80% of the participants will complete the study, a single full-time investigator can deliver
the intervention to 15 participants over 3 months and data collection will be thorough (with
less than 5% missing data). The investigators also hypothesised that this feasibility study
will help improve the intervention and help the design of a larger trial.
| Status | Completed |
| Enrollment | 17 |
| Est. completion date | December 2014 |
| Est. primary completion date | December 2014 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 16 Years and older |
| Eligibility |
Inclusion Criteria: - adult people with CF looked after at the Sheffield Adult CF Unit - best BMI of < 23 for males and < 22 for females between Oct '12 and Oct '13 Exclusion Criteria: - patients in the palliative phase of disease - patients who are pregnant - patients who have no capacity to consent to participate in the study - patients who have no IT facilities to use the web-based food diary - patients who are unable to communicate by telephone for coaching |
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Health Services Research
| Country | Name | City | State |
|---|---|---|---|
| United Kingdom | Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust | Sheffield | South Yorkshire |
| Lead Sponsor | Collaborator |
|---|---|
| Sheffield Teaching Hospitals NHS Foundation Trust |
United Kingdom,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Body mass index | Unit is kg/m2 | 6 months | No |
| Other | Weight | unit is kg | 6 months | No |
| Other | Beliefs about Medicines Questionnaire (BMQ) score | As a marker of patients' perception of their treatment | 6 months | No |
| Other | The mean Self-Report Behavioural Automaticity Index (SRBAI) score | As a marker of habit formation | 6 months | No |
| Primary | Proportion of patients who accepted invitation to participate as a marker of feasibility | 4 weeks | No | |
| Primary | Proportion of people with CF who are randomised into the study after accepting the invitation to participate, as a marker of feasibility | 4 weeks | No | |
| Secondary | Participants' opinion about the behavioural intervention | 6 months | No | |
| Secondary | Participant attrition rate and phases of study whereby the attrition occurs | 6 months | No | |
| Secondary | Participants' opinion about the study processes | 6 months | No | |
| Secondary | Participants' suggestions for further improvement of the intervention and study processes | 6 months | No | |
| Secondary | Proportion of adults who fulfils the BMI criteria for recruitment with IT facilities | 2 weeks | No | |
| Secondary | Resources needed by the investigators to deliver the intervention | 6 months | No | |
| Secondary | Proportion of days with missing nutritional data, as a marker for feasibility | Participants are requested to fill in their nutritional intake daily on a web-based food diary. The investigators are interested to find out what the proportion of such data will be missing to determine the feasibility of collecting data with the web-based food diary. | 6 months | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04696198 -
Thoracic Mobility in Cystic Fibrosis Care
|
N/A | |
| Completed |
NCT00803205 -
Study of Ataluren (PTC124™) in Cystic Fibrosis
|
Phase 3 | |
| Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
| Completed |
NCT03601637 -
Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Participants 1 to Less Than 2 Years of Age With Cystic Fibrosis, Homozygous for F508del
|
Phase 3 | |
| Terminated |
NCT02769637 -
Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)
|
||
| Recruiting |
NCT06030206 -
Lung Transplant READY CF 2: A Multi-site RCT
|
N/A | |
| Recruiting |
NCT06012084 -
The Development and Evaluation of iCF-PWR for Healthy Siblings of Individuals With Cystic Fibrosis
|
N/A | |
| Recruiting |
NCT06032273 -
Lung Transplant READY CF 2: CARING CF Ancillary RCT
|
N/A | |
| Recruiting |
NCT05392855 -
Symptom Based Performance of Airway Clearance After Starting Highly Effective Modulators for Cystic Fibrosis (SPACE-CF)
|
N/A | |
| Recruiting |
NCT06088485 -
The Effect of Bone Mineral Density in Patients With Adult Cystic Fibrosis
|
||
| Recruiting |
NCT04056702 -
Impact of Triple Combination CFTR Therapy on Sinus Disease.
|
||
| Recruiting |
NCT04039087 -
Sildenafil Exercise: Role of PDE5 Inhibition
|
Phase 2/Phase 3 | |
| Completed |
NCT04058548 -
Clinical Utility of the 1-minute Sit to Stand Test as a Measure of Submaximal Exercise Tolerance in Patients With Cystic Fibrosis During Acute Pulmonary Exacerbation
|
N/A | |
| Completed |
NCT04038710 -
Clinical Outcomes of Triple Combination Therapy in Severe Cystic Fibrosis Disease.
|
||
| Completed |
NCT03637504 -
Feasibility of a Mobile Medication Plan Application in CF Patient Care
|
N/A | |
| Recruiting |
NCT03506061 -
Trikafta in Cystic Fibrosis Patients
|
Phase 2 | |
| Completed |
NCT03566550 -
Gut Imaging for Function & Transit in Cystic Fibrosis Study 1
|
||
| Recruiting |
NCT04828382 -
Prospective Study of Pregnancy in Women With Cystic Fibrosis
|
||
| Completed |
NCT04568980 -
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
|
||
| Recruiting |
NCT04010253 -
Impact of Bronchial Drainage Technique by the Medical Device Simeox® on Respiratory Function and Symptoms in Adult Patients With Cystic Fibrosis
|
N/A |